This is a Validated Antibody Database (VAD) review about human NKX3 1, based on 6 published articles (read how Labome selects the articles), using NKX3 1 antibody in all methods. It is aimed to help Labome visitors find the most suited NKX3 1 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
NKX3 1 synonym: BAPX2; NKX3; NKX3.1; NKX3A

Abcam
domestic rabbit monoclonal (EPR16653)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig s1h
Abcam NKX3 1 antibody (Abcam, ab196020) was used in immunohistochemistry - paraffin section on mouse samples (fig s1h). Cell Death Dis (2022) ncbi
Invitrogen
mouse monoclonal (3 9)
  • western blot; human
In order to study the roles of prostate tumor suppressor NKX3.1 in DNA repair and luminal cell differentiation, Invitrogen NKX3 1 antibody (Invitrogen, 35-9700) was used in western blot on human samples . F1000Res (2014) ncbi
mouse monoclonal (3 9)
  • immunohistochemistry; human; 1:250
In order to investigate the prognostic significance of a three-protein biomarker panel for prostate cancer, Invitrogen NKX3 1 antibody (Zymed, 35-9700) was used in immunohistochemistry on human samples at 1:250. Cancer Med (2014) ncbi
mouse monoclonal (3 9)
  • ChIP-Seq; human; fig 3
In order to elucidate the metastatic process, Invitrogen NKX3 1 antibody (Zymed, 35-9700) was used in ChIP-Seq on human samples (fig 3). Cancer Cell Int (2013) ncbi
Cell Marque
domestic rabbit monoclonal (EP356)
  • immunohistochemistry - paraffin section; human; fig 1e
Cell Marque NKX3 1 antibody (CellMarque, EP356) was used in immunohistochemistry - paraffin section on human samples (fig 1e). Diagn Cytopathol (2017) ncbi
domestic rabbit monoclonal (EP356)
  • immunohistochemistry - frozen section; human; 1:200; fig 1g
Cell Marque NKX3 1 antibody (Cell Marque, EP356) was used in immunohistochemistry - frozen section on human samples at 1:200 (fig 1g). Int J Mol Sci (2017) ncbi
Articles Reviewed
  1. Wu T, Wang W, Shi G, Hao M, Wang Y, Yao M, et al. Targeting HIC1/TGF-β axis-shaped prostate cancer microenvironment restrains its progression. Cell Death Dis. 2022;13:624 pubmed publisher
  2. Jia L, Jiang Y, Michael C. Performance of different prostate specific antibodies in the cytological diagnosis of metastatic prostate adenocarcinoma. Diagn Cytopathol. 2017;45:998-1004 pubmed publisher
  3. Kristiansen I, Stephan C, Jung K, Dietel M, Rieger A, Tolkach Y, et al. Sensitivity of HOXB13 as a Diagnostic Immunohistochemical Marker of Prostatic Origin in Prostate Cancer Metastases: Comparison to PSA, Prostein, Androgen Receptor, ERG, NKX3.1, PSAP, and PSMA. Int J Mol Sci. 2017;18: pubmed publisher
  4. Yang C, Chung A, Ku C, Brill L, Williams R, Wolf D. Systems analysis of the prostate tumor suppressor NKX3.1 supports roles in DNA repair and luminal cell differentiation. F1000Res. 2014;3:115 pubmed publisher
  5. Severi G, FitzGerald L, Muller D, Pedersen J, Longano A, Southey M, et al. A three-protein biomarker panel assessed in diagnostic tissue predicts death from prostate cancer for men with localized disease. Cancer Med. 2014;3:1266-74 pubmed publisher
  6. Eide T, Ramberg H, Glackin C, Tindall D, Taskén K. TWIST1, A novel androgen-regulated gene, is a target for NKX3-1 in prostate cancer cells. Cancer Cell Int. 2013;13:4 pubmed publisher